TCF Financial Corporation (NYSE:TCB) started its trading session with the price of $15.42, and closed at $15.31 by scoring -0.71%. The 52 week range of the stock was $10.06 -$16.68. TCB traded with total volume of 1,689,100 shares, while the average trading volume remained 1.72 million shares. The beta of the stock stands at 0.67.

TCF Financial Corporation operates as the bank holding company for TCF National Bank that provides various retail and wholesale banking products and services.

WPX Energy Inc (NYSE:WPX) traded during its last trading session with the total volume of 1,663,600 shares, as compared to its average volume of 2.23 million shares. During the previous session, the company’s minimum price was $19.07 while it touched its highest price for the day at $19.70. In most recent session, the stock advanced +2.76% and closed the trading activity at $19.70.

The stock was a bull in its 3 months performances of +20.20% and the 6 months performance of the stock remained +33.20%.

WPX Energy, Inc., an independent natural gas and oil exploration and production company, engages in the exploitation and development of unconventional properties.

Exelis Inc (NYSE:XLS) its number of shares traded in the last trading day were 1,619,700, on the other hand, its average trading volume was 1.16 million shares. In prior session, the stock advanced +2.86% and closed the trading activity at $15.45. Watching the stock’s previous 5 day trend, the stock showed a bullish move of +4.04%. Yesterday, the market capitalization of the stock remained 2.91 billion.

Exelis Inc. provides command, control, communications, computers, intelligence, and surveillance and reconnaissance (C4ISR) related products and systems in the United States and internationally.

CEL-SCI Corporation (NYSEMKT:CVM) opened the most recent session at the price of $0.26, whereas its previous closing price was recorded at $0.251. CVM gained +5.24% and traded within the range of $0.25 - $0.27 in prior trading activity. The 52 week range of the stock remained in between $0.16 - $0.43. Total volume of the stock was 4,985,600 shares during last trade, while its average volume remained 1.43 million shares.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company?s principal product, Multikine, is under Phase III clinical trial for the treatment of head and neck cancer.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.